75 related articles for article (PubMed ID: 17940562)
21. Involvement of p29/SYF2/fSAP29/NTC31 in the progression of NSCLC via modulating cell proliferation.
Liu Y; Ni T; Xue Q; Lv L; Chen B; Cui X; Cui Y; Wang Y; Mao G; Ji L
Pathol Res Pract; 2015 Jan; 211(1):36-42. PubMed ID: 25433998
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between the expression of PRDM14 in non-small cell lung cancer and the clinicopathologic characteristics].
Liu B; Zhang S; Hui L; Qiu X; Cui Z
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):867-72. PubMed ID: 20840815
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
24. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of MTA2 in non-small cell lung cancer].
Wang S; Qi Y; Zhang J; Zhang Q; Li H; Qiu X
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):777-80. PubMed ID: 20704817
[TBL] [Abstract][Full Text] [Related]
26. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
[TBL] [Abstract][Full Text] [Related]
27. [Expression of EYA2 in non-small cell lang cancer].
Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
[TBL] [Abstract][Full Text] [Related]
28. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
29. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
30. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer].
Su M; Gu Y; Su S; Lu B
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912
[TBL] [Abstract][Full Text] [Related]
31. [Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
Zhao ZL; Huang QY; Xu S; Zhang L; Zhao HR
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3362-6. PubMed ID: 17313836
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
33. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
34. [AP-2 expression and significance in the lung cancer tissues].
Zhou R; Chen P; Zhang GS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):195-7. PubMed ID: 16145912
[TBL] [Abstract][Full Text] [Related]
35. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
37. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
38. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer].
Zhao X; Tuo H; Si M; Wang L; Liang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
40. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
